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Abstract
Background: Advances in magnetic resonance imaging and the introduction of clinical decision support systems has underlined
the need for an analysis tool to extract and analyze relevant information from magnetic resonance imaging data to aid decision
making, prevent errors, and enhance health care.
Objective: The aim of this study was to design and develop a modular medical image region of interest analysis tool and
repository (MIROR) for automatic processing, classification, evaluation, and representation of advanced magnetic resonance
imaging data.
Methods: The clinical decision support system was developed and evaluated for diffusion-weighted imaging of body tumors
in children (cohort of 48 children, with 37 malignant and 11 benign tumors). Mevislab software and Python have been used for
the development of MIROR. Regions of interests were drawn around benign and malignant body tumors on different diffusion
parametric maps, and extracted information was used to discriminate the malignant tumors from benign tumors.
Results: Using MIROR, the various histogram parameters derived for each tumor case when compared with the information in
the repository provided additional information for tumor characterization and facilitated the discrimination between benign and
malignant tumors. Clinical decision support system cross-validation showed high sensitivity and specificity in discriminating
between these tumor groups using histogram parameters.
Conclusions: MIROR, as a diagnostic tool and repository, allowed the interpretation and analysis of magnetic resonance imaging
images to be more accessible and comprehensive for clinicians. It aims to increase clinicians’ skillset by introducing newer
techniques and up-to-date findings to their repertoire and make information from previous cases available to aid decision making.
The modular-based format of the tool allows integration of analyses that are not readily available clinically and streamlines the
future developments.
(JMIR Med Inform 2018;6(2):e30)   doi:10.2196/medinform.9171
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Introduction
Magnetic resonance imaging (MRI) is a fast-growing clinical
imaging modality and has become the modality of choice for
the evaluation of disease and treatment management across
multiple therapeutic areas. It has increasingly been used in
oncology, central nervous system diseases, musculoskeletal
disorders, and cardiovascular disease due to its superior
soft-tissue imaging capabilities, lack of ionizing radiation, and
noninvasive nature [1-4].
MRI technology constantly advances with new magnetic
resonance applications being pioneered, investigated,
mainstreamed, and added to clinical applications and
capabilities. Nevertheless, clinical interpretation remains largely
by qualitative expert review. In addition, new advanced and
computationally intensive medical quantitative image analysis
techniques are constantly being developed and validated. These
techniques have allowed the discovery of specific biomarkers
of both disease and treatment response and have exposed
clinicians to new information in a computable format [5-8].
However, the growing and versatile amount of magnetic
resonance–derived information can form an insurmountable
obstacle to the individual clinician; in particular, the use of
quantitative MRI biomarkers requires further improvement in
accessibility and presentation to aid decision making [9].
In the past decade, clinical decision support (CDS) systems
have increasingly gained attention, and the routine uptake of
these intelligent systems is becoming more common [10-17].
Introduction of CDSs has provided clinicians and health care
investigators with a platform for extraction of relevant
information to aid decision making, prevent errors, and enhance
health care. CDSs include a range of options from computerized
alerts, reminders, and clinical guidelines to diagnostic support
and clinical workflow through computer-assisted diagnosis tools
(CAD) [18-26]. There are several clinically implemented or
research-based CADs available for medical image analysis
[23,26-29]. However, majority of them lack at least one of the
following: (1) a user-friendly graphical interface to be used by
clinicians in their clinical routine; (2) system performance is
often not compared with radiologist diagnosis in the absence
of the tool or when the tool is utilized; (3) are not MRI based;
(4) are designed for one particular disease; and (5) are just a
single postprocessing tool or analysis algorithm, which also
provides a likelihood for a disease and does not offer decision
support for the clinicians (ie, in form of only providing
additional structured information for comparison with available
other relevant diagnosis). These types of solutions have shown
to suffer from high false positives [9].
Availability of a user-friendly and flexible MRI CAD that
encompasses a variety of medical image analysis techniques
and postprocessing methods and can act as a CDS could
facilitate the uptake of new advanced magnetic resonance
techniques in the real-time clinical setting; it could also allow
health care investigators to interrogate their data in a
scientifically informative and convenient manner to determine
a robust and efficient diagnosis. The aim of this study was to
design, develop, and evaluate a medical image region of interest
analysis tool and repository (MIROR) platform for conventional
magnetic resonance data aimed at improving clinical
performance through the provision of real-time diagnostic
support for clinicians.
To the best of our knowledge, there is only the International
Network for Pattern Recognition of Tumours Using Magnetic
Resonance Decision Support System validated and available
for the analysis of magnetic resonance spectroscopy (MRS)
data [30]. However, this CDS is developed for diagnosing and
grading adult brain tumors and is based on MRS only. There is
no CDS for both MRI and MRS analysis with a robust user
interface for clinical routine use that is capable of creating and
updating a validated repository for different diagnostic problems.
Methods
Clinical Decision Support System Design
Features available in the presented version of the MIROR are
(1) a clinician-friendly graphical user interface; (2) measurement
of morphologic properties such as size, shape, volume, length
dimensions, and center-of-mass location of the region of interest
(ROI); (3) an integrated magnetic resonance diffusion-weighted
imaging (DWI) analysis application based on intravoxel
incoherent motion (IVIM) model; (4) statistical data analysis
of the ROI overlaid on standard MRI images (such as
T1-weighted and T2-weighted scans or the advanced quantitative
maps) to provide decision support in forms of comparison with
other differential diagnosis and several different image volumes
to aid diagnosis and determination of prognosis; and (5) a
self-archiving repository of the extracted data and features.
Availability of the latter 2 options in combination with the first
3 will move the designed tool from a CAD toward becoming a
CDS for MRI data. MIROR also allows investigators to further
grow, advance, and combine different analysis techniques and
types of imaging sequences to extend the tool to a more
sophisticated decision support, dependent on their individual
center’s needs to better inform diagnosis. MIROR’s
self-archiving, evolving repository is the core of its decision
support. This unique feature of the MIROR distinguishes it from
pervious CADs and CDSs. First, the repository’s continuous
development allows for improvement in the predication accuracy
for the available biomarkers and disease in the database; second,
it permits provision of a decision support system compatible to
additional disease types by means of importing and appending
the repository.
We used a modular and open architecture design [23] in the
design and implementation of MIROR to be able to adapt to the
constant increase and development in the MRI sequences; it
will also make room for consequent advances in the related
analysis applications and allow future development of additional
new workflows. Additionally, we used Mevislab software (v.
2.7.1, MeVis AG- Fraunhofer-MEVIS) [31,32], a research-based
rapid prototyping platform for medical image processing, for
development of the MIROR to achieve the latter. Post
processing, quantitative and statistical analysis functionalities
embedded in MIROR were either developed using Python (v.
2.7, embedded within Mevislab) or were imported from the
Mevislab library. The MIROR repository was developed using
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Python. Each individual independent module of MIROR was
developed, evaluated, and tested by different groups within the
team in their own life cycle and schedules before addition to
the final product. A hierarchical structure of MIROR
infrastructure is represented in Figure 1. MIROR self-archiving,
evolving repository is the core of its decision support. This
feature of the MIROR distinguishes it from pervious
computer-assisted diagnosis tools (CADs) and CDSs.
Based on the recommendations of the American medical
informatics association [33], an evidence-adaptive approach
was employed in the design of the MIROR by utilizing its
knowledge base to derive from—and reflect on—the most
up-to-date evidence from the research literature and
practice-based sources [34]. The statistical and quantitative
analysis module embedded in MIROR are developed based on
the literature and local practice-based research and will continue
to update in future releases. MIROR is an evolving database of
available diagnosis data gathered from routine clinical practice.
Outcomes of this repository data analysis can inform future
clinical investigations, reflect on the clinical practice, and
consequently impact on the MIROR statistical and quantitative
analysis module. Conversely, practice-based experience can
inform the choice of MRI sequence and parametric maps to be
used for analysis and clinical evaluation (Figure 2).
MIROR can import all file formats supported by the National
Library of Medicine Insight Segmentation and Registration
Toolkit, such as digital imaging and communications in
medicine (DICOM) files, Neuroimaging Informatics Technology
Initiative files, JPEG as well as text files, and comma
spreadsheets. Built-in Mevislab modules and Python were used
to create this functionality. Using the module raw images,
postprocessed quantitative maps and data files can be imported
from the clinical data warehouses, such as hospital picture
archiving and communication system (PACS), the local servers,
or MIROR for future analysis and visualization (Figure 1).
Comparing the MIROR architecture with previously developed
CDSs with a clinical data base and domain expert knowledge
base, MIROR does not connect to hospital electronic health
record (EHR) system or any Internet-based database or medical
knowledge representations or guidelines [10,35,36]. Having
said so, one should note that imaging data can be imported to
MIROR through connection to hospital PACS and therefore
can be considered as a semi-integrated CDSs [37]. Moreover,
currently available active and robust CDSs benefit from EHR
data with very large and historical dataset that changes
continuously and contains hidden knowledge. MIROR was
designed based on a similar architecture applied to a repository
containing a constantly updated independent database. The
updating of the database allows the advanced MRI biomarkers
to be revised whenever new data are available.
One of the main strengths of MIROR is its ability to allow for
integration of new advanced and computationally intensive
quantitative analyses that are not readily available to be used in
routine clinical practice under the Advance Quantitative analysis
module (Figure 1). In this study, the analysis of multi b-value
(b=diffusion weightings) magnetic resonance DWI is embedded
in MIROR. The analysis was developed using the
well-established and not clinically available intravoxel
incoherent motion (IVIM) model, which has been shown to
have clinical value in many different tumor types [38-40] as
well as in other pathologies [41,42]. Although IVIM provides
a similar measure to clinically available apparent diffusion
coefficient (ADC), derivation of the additional parameters allows
the separation of the perfusion contribution from the true
diffusion, resulting in a greater insight to the underlying tissue
microenvironment [43-45].
Figure 1. Flow diagram showing hierarchical structure of the medical image region of interest analysis tool and repository (MIROR) infrastructure.
Dashed blue lines indicate direct connection of the module output to the front-end display, solid lines are the connections between internal clinical
decision support (CDS) modules, and green dashed lines represent the feedback system to the repository. PACS: picture archiving and communication
system; ROI: region of interest; MRI: magnetic resonance imaging. MRI: magnetic resonance imaging; DICOM: digital imaging and communications
in medicine.
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Figure 2. Medical Image Region of interest analysis tool and Repository (MIROR) evidence-adaptive protocol. An evidence-adaptive approach was
utilized in the design of the MIROR by utilizing its knowledge base to derive from and reflect on the most up-to-date evidence from the research literature
and practice-based sources.
This analysis allows the computation of tissue diffusion
coefficient (IVIM-D), pseudo-diffusion coefficient (IVIM-D*),
and perfusion fraction (IVIM-f) [46]. However, as a relatively
new analysis method, it is currently not available as part of the
scanner software packages. The MIROR IVIM module, which
is developed using python programming, loads the raw DWI
DICOM file and based on it determines whether the IVIM
analysis is feasible, based on the number of the b values. The
output from the module is the IVIM parameter maps, which can
then be used for further ROI-based statistical analysis.
The MIROR-embedded statistical analysis module provides
specialists with instruments for (1) analyzing and interpreting
individual patient MRI data and (2) comparing it with results
of previous cases directly from the MIROR-evolving repository
via powerful statistical techniques to future inform the
investigation (Figure 1). MIROR provides statistical analysis
of the advanced parametric maps or the standard MRI sequence
image’s ROI (ie, diffusion maps produced in MIROR, other
imported advance quantitative maps, or T1-weighted and
T2-weighted scans). It measures the volume of the defined ROI,
creates a histogram for it, performs statistical analysis on the
ROI values, and extracts and stores histogram parameters such
as entropy, median, mean, different quantiles, skewness, and
kurtosis in its repository. Unlike previously reported CAD and
CDS tools, using MIROR the medical expert has multiple
options, including (1) selection of the population of interest
from the repository to work only with data from a specific
condition, (2) choosing the MRI biomarker/variable (eg,
diffusion, perfusion), and (3) the statistical variable of interest
from a complete set of basic and advanced features that cover
both clinical and research needs (basic statistics mean, median,
variance, standard deviation, quantile, histogram analysis, etc).
Note that MIROR is a nonregion-specific MRI CDS, and its
novel quantitative image analysis and statistical analysis
modules are designed to analyze any region of the body and aid
in resolving different demanding diagnostic problems.
The frontend of the MIROR is a clinician’s user-friendly
graphical interface that displays MRI images as well as
quantified parametric maps and allows clinicians to define their
ROI. It also provides real-time morphological and statistical
results for compassion with the repository data so as to aid
clinical evaluation of the disease.
Medical Image Region of Interest Analysis Tool and
Repository Application to Pediatric Tumor Evaluation
MIROR is currently being developed, evaluated, and used at
Birmingham Children’s Hospital to determine its role in
facilitating noninvasive diagnosis in children presenting with
solid body tumors in clinical practice.
Solid masses in children represent a diagnostic dilemma, as
neoplastic and non-neoplastic lesions can appear similar on
conventional imaging. Although in some cases the clinical
history and physical examination findings indicate a likely
diagnosis, the majority of cases require further evaluation with
MRI to assess the extent of the lesion and make a specific
diagnosis. It is often difficult to determine whether a lesion is
benign or malignant or identify specific tumor type based on
conventional MRI alone.
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Table 1. Body tumor patient cohort demographics.
Patients, nDiagnosisGenderMedian age (range)Tumor
1Liver hemangiomaFemale=6; Male=73.63 (0.03-14.22)Benign
4Ganglioneuroma
1Hematocolpos
1Lipoma
1Infantile myofibromatosis
2Mesoblastic nephroma
1Hematocolpos
1Vascular malformation
1Ovarian immature teratoma
1Clear cell sarcoma of kidneyFemale=16; Male=213.94 (0.03-11.82)Malignant
1Ewing's sarcoma
1Germ cell tumor
4Hepatoblastoma
11Neuroblastoma
1Osteosarcoma
2Rhabdoid tumor
3Rhabdomyosarcoma
13Wilms tumor
This study evaluated the impact of information provided by
MIROR in aiding clinicians to distinguish between benign and
malignant solid body pediatric tumor types using DWI.
Accuracy testing involved examination of MIROR for a cohort
of real patient cases with recent visits to Birmingham Children’s
Hospital and comparison of the MIROR outcome with the
radiologist’s initial opinion and final diagnosis derived based
on the opinion of the clinical multidisciplinary team of experts
together with pathology.
Magnetic Resonance Imaging Data
The body tumor patient cohort studied consisted of children
(aged 0-16 years) with solid tumors, undergoing diagnostic MRI
with multi b-value DWI at Birmingham Children’s Hospital
from 2012 to September 2016. A total of 48 children were
enrolled, of whom 37 had malignant tumors and the rest had
benign tumors. Details of the malignant and benign body tumors
along with patients’ demographics are presented in Table 1.
We performed the MRI on a Siemens Avanto 1.5 T MRI scanner
(Siemens Healthcare, Erlangen, Germany). The
diffusion-weighted MRI protocol used an echo-planar imaging
sequence in an axial acquisition plane with a field-of-view
(FOV) 221 to 350 × 172 to 317 mm2, matrix size 122 to 192 ×
128 to 192, slice thickness of 5 mm, and in-plane resolution of
1.56 × 1.56 mm2. For all subjects, 6 b-values: 0, 50, 100, 150,
600, and 1000 s/mm2 were acquired in 3 orthogonal directions
with TR/TE=3200 to 9900/92 ms and number of averages=3.
The signal to noise of the MRI dataset was approximately 30
(SD 10) for b1000 and 60 (SD 10) for b0 images.
Depending on their ability to cooperate, children were awake,
sedated, or under general anesthesia. MRI acquired with
different diffusion weightings (b-values) was used to compute
ADC (computed from b0 and b1000), IVIM-D, IVIM-D*, and
IVIM-f maps. These values are a quantitative measure of
diffusion related to tissue cellularity [45,47] and can be useful
for tumor characterization. Clinicians currently only use ADC
maps in a qualitative manner to help tumor characterization,
commenting on restriction of diffusion as a possible marker of
malignancy. Advanced quantitative diffusion parameters (ie,
IVIM-D, IVIM-D*, and IVIM-f) and means for direct and
real-time statistical analysis of these variables are unavailable
clinically, despite the growing body of evidence for their
potential value in noninvasive diagnosis.
Discrimination Between Benign and Malignant Tumor
Types
To discriminate between malignant and benign tumors, the
authors made use of a leave-one-out cross-validation method
combined with a {displaystyle C_{30}^{100}approx 3times
10^{25}.} threshold-based classification approach to determine
the potential of individual parameters determined by MIROR.
To achieve this, one case of the cohort was assigned in turn as
the validation case, with the remaining ones used for training
to inform the outcome. The selected validation case was then
iteratively changed until all cases had been evaluated exactly
once. On the basis of the threshold approach, if the value of the
case under study lay within 1 standard deviation of the mean
of a statistical parameter of the training tumor group (ie, benign
or malignant), it was assigned to that particular group. However,
if the value of the parameter under study fell within both tumor
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group regions, we made use of second-adjusted classification
based on distance from the mean of the statistical parameter of
the groups in the training set. To further evaluate the significance
of the statistical parameters and information provided by
MIROR, k-nearest neighbor (KNN) and support vector machine
(SVM) pattern recognition techniques, followed by
leave-one-out cross-validation, were utilized to test the accuracy
of derived data in distinguishing between tumor types, using
all parameters as classification features. KNN was chosen for
its simplicity and performance on basic recognition problems;
it has been a ubiquitous classification method with good
scalability. SVM outperforms conventional pattern recognition
methods, especially when the number of training data is small
and number of input variables is large [48].
To account for the data skewness and imbalanced distribution
of the 2 groups, synthetic minority oversampling technique has
been used to allow for building a larger decision region that
contains nearby instances of the minority class [49] when KNN
and SVM are used.
Feature selection was performed before classification by means
of calculating the significance level of the histogram derived
parameters between the tumor groups. Then, benign and
malignant tumors’ histogram permanents (ie, Median; 2nd, 5th,
10th, 15th, 25th, 75th, 85th, 90th, and 98th centile values;
kurtosis; skewness; and entropy) were compared using the
nonparametric Mann-Whitney U test. The authors used the
Bonferroni correction method. Parameters showing a significant
difference between the 2 groups were used for classification.
All statistical analyses were performed using SPSS Statistics
(v. 23, Chicago, Illinois) software.
All patients were consented for research to the UK Children’s
Cancer and Leukemia Group, Functional Imaging Group
database, a UK National Health Service Research Ethics
committee-approved study (Reference number 04/MRE04/41,
Health Research Authority East Midlands—Derby, UK, Ethical
Review Board Chair, Dr Peter Korczak). Informed participation
and publication consent was given by parents/guardians.
MIROR is aimed at improving clinical practice through the
provision of real-time diagnostic support. To ensure achievement
of the latter, each individual application and module has been
tested in such an environment by allowing clinicians to
interrogate it about the most important clinical questions and
provide feedback. We used an iterative process of design,
testing, and revision of the MIROR by a diverse team, including
medical informatics experts, clinical content experts, and end
users to ensure reliable translation of the tool to clinical practice.
Experts in MRI and medical imaging, including PhD researchers
specializing in MRI and data processing, a physician, and a
senior consultant radiologist pilot tested MIROR iteratively
during the development and refinement of the tool.
Results
MRI datasets and ADC produced by the scanner were imported
to MIROR from a local PACS. An ROI was drawn around the
entire solid tumor for each case on a high-resolution image by
one clinician, which was then checked by another (KM and KF)
before being transferred to a matched parametric map (eg, ADC
and IVIM maps). The entire tumor volume, including cystic
and necrotic areas, was included in the ROI to determine
representative data for heterogeneous tumors [50]. A histogram
of the drawn ROI was constructed; the mean, median, 2nd-98th
percentile values, skewness, kurtosis, and entropy of the
histograms were calculated for all tumors, recorded, and stored
on a database. Figure 3 demonstrates a screenshot of MIROR
for all of the described stages. Advance IVIM parametric maps
D and f are also shown in Figure 4.
Figure 5 represents an example of MIROR’s decision support
module for evaluating benign and malignant cases.
To establish differences between the malignant and benign
lesions histogram parameters, the authors compared the
histogram-derived parameters in the repository. Analysis showed
apparent differences between malignant and benign tumors,
with lower ADC values and higher skewness and kurtosis in
malignant lesions. There was no significant difference between
85th (P=.12), 90th (P=.22), 95th (P=.82), or 98th centile (P=.41)
ADC values between benign and malignant tumors (Table 2).
Malignant tumors demonstrated statistically significantly lower
mean (P=.03), median (P=.005), 2nd (P=.04), 5th (P=.02), 10th
(P=.01), 15th (P=.005), 25th (P=.004), and 75th centile (P=.03)
ADC values, higher kurtosis (P<.01), more positively skewed
histograms (P<.001), and higher entropy (P=.03). These results
are in agreement with similar studies published for adults
[51-53].
The feasibility of MIROR to provide distinctive surplus
information, which would further aid diagnosis, was evaluated
using histogram-derived parameters with the statistically
significant differences between the 2 groups. The accuracy of
individual statistical parameters to discriminate between specific
benign or malignant tumors is presented in Table 3. Due to the
high correlation between the ADC centiles, only 15% and 75%
centiles were used for classification.
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Figure 3. Medical image region of interest analysis tool and repository (MIROR) user-interface patient view. This figure represents data for a malignant
tumor case. Here, the region of interest (ROI) is drawn on a high-resolution image and overlaid on the corresponding parametric apparent diffusion
coefficient (ADC) map. Measurement of morphologic properties of the ROI, zooming, scaling, rotating of the estimated object surface, and histogram
analysis of the overlaid ROI on voxel-by-voxel parametric maps, is supported to enhance quality assessment.
Figure 4. Medical image region of interest analysis tool and repository (MIROR) user-interface intravoxel incoherent motion (IVIM) maps tabs. This
figure represents data for a malignant tumor case. Here, the region of interest (ROI) is drawn on a high-resolution image and overlaid on the corresponding
parametric map IVIM-D and IVIM-f. Measurement of morphologic properties of the ROI, zooming, scaling, rotating of the estimated object surface
and histogram analysis of the overlaid ROI on voxel-by-voxel parametric maps, is supported to enhance quality assessment.
JMIR Med Inform 2018 | vol. 6 | iss. 2 | e30 | p.7http://medinform.jmir.org/2018/2/e30/
(page number not for citation purposes)
Zarinabad et alJMIR MEDICAL INFORMATICS
XSL•FO
RenderX
Figure 5. Medical image region of interest analysis tool and repository (MIROR) user-interface analysis tab. This figure represents MIROR use as a
decision support system for benign and malignant cases. Here, the green histogram line represents the index case under examination; the red line and
gray area represent the mean and standard deviation of the selected tumor group for comparison, respectively. The box plot compares median, skewness,
entropy, and 25th percentile values of the index case with the tumor types in the database.
In the studied cohort, skewness, kurtosis, entropy, different
percentiles, mean, and median provided important distinctive
additional information, which was not available by using
qualitative approaches only. Using kurtosis, entropy and 15th
percentile for threshold-based classification, 100% of malignant
cases were correctly assigned. Mean, median, and skewness
had an accuracy of 0.97 in classifying malignant cases. In the
benign category, kurtosis, entropy, and 75th percentile achieved
full accuracy. Mean and median had an accuracy of 0.91 in
classifying benign tumors. Overall, kurtosis and entropy had
the highest sensitivity and specificity (sensitivity=1,
specificity=1) in discriminating between benign and malignant
tumors. Note that the threshold classification was performed
based on a single feature input and a 2-step classification
process, with a less strict rule in second layer to reclassify the
cases in the ambiguous group. Using all of the above extracted
features, more advanced pattern recognition techniques, and
10-fold cross-validation, an accuracy of 0.89 (sensitivity=0.97,
specificity=0.5, area under the curve [AUC]=0.78) and 0.93
(sensitivity=0.97, specificity=0.58, AUC=0.84) was obtained
by SVM and KNN, respectively. Figure 6 shows a comparison
of the classifiers using 10-fold cross-validation receiver
operating characteristic analysis.
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Table 2. Comparison of apparent diffusion coefficient (ADC) histogram parameters between malignant and benign pediatric tumors using the
Mann-Whitney U test.
P valueParameters
.03aMean
.005aMedian
<.01aKurtosis
<.01aSkewness
.03aEntropy
.04a2% percentile
.02a5% percentile
.01a10% percentile
.005a15% percentile
.004a25% percentile
.03a75% percentile
.1285% percentile
.2290% percentile
.8295% percentile
.4198% percentile
aStatistical significance P<.05.
Table 3. Accuracy of individual statistical parameters along with sensitivity and specificity of the analysis obtained by medical image region of interest
analysis tool and repository (MIROR) to discriminate between benign or malignant tumors using 2-step threshold classifications.
75% percentile15% percentileEntropySkewnessKurtosisMedianMeanMarker
1319 (SD 329)710 (SD 201)7.1 (SD 0.42)0.02 (SD 0.004)2.1 (SD 0.09)996 (SD 262)1098 (SD 295)Malignant
1683 ( SD 538)1072 (SD 406)6.85 (SD 0.4)0.0007 (SD 0.01 )2.031 (SD 0.11)1442 (SD 511)1443 (SD 462)Benign
0.97110.9710.970.94Sensitivity
10.8310.5810.910.91Specificity
0.9870.916510.695510.94550.932Accuracy
To further evaluate MIROR in terms of its added clinical value,
radiologist initial diagnosis from the first MRI scans was
compared with the final diagnosis obtained from histopathology,
and the outcome of the 3 statistical analyses based on MIROR
provided information for classifying the tumor types for this
cohort of patients (Figure 7). For the 2-step thresholding
classification, outcome of the first classification layer is
presented to include the ambiguous group. The ambiguous
groups for KNN and SVM were identified by thresholding their
predication probabilities at above 0.8 and above 0.5 for the
accurate and ambiguous assignment of cases, respectively.
A higher amount of uncertainty was observed in the initial
diagnosis of the benign group. The benign group diagnostic
uncertainty rate decreased when we used the information
provided by MIROR. Moreover, the false diagnosis rate for
both the malignant and benign groups was reduced compared
with the radiologist’s initial report with all 3 analysis methods.
Additional statistical information provided to clinicians by
MIROR can allow for a better and more informed noninvasive
discrimination of benign and malignant body tumors in children.
Net reclassification improvement (NRI) [54] for KNN, SVM,
and the 2-step thresholding methods using the histogram
parameters were calculated to evaluate the level of improvement
achieved by these methods compared with the radiologist’s
initial reading . The same is presented in Figure 8. KNN had
the highest incremental value (NRI=0.35) among all the
methods. Histogram parameters on average had a NRI of 0.19
in comparison with the radiologist’s initial read.
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Figure 6. Receiver operating characteristic (ROC) curves of support vector machine and k-nearest neighbor (KNN) in discriminating benign from
malignant tumors using medical image region of interest analysis tool and repository (MIROR)-derived parameters. Area under the curve (AUC) was
0.78 for support vector machine (SVM) and 0.84 for KNN.
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Figure 7. Radiologist’s initial diagnosis compared with final diagnosis after histopathology for different tumor types, along with the comparison between
Medical Image Region of interest analysis tool and Repository (MIROR) performance evaluated by support vector machine (SVM), k-nearest neighbor
(KNN), and 2-step threshold classification methods.
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Figure 8. Net reclassification improvement (NRI) for k-nearest neighbor (KNN), support vector machine (SVM), and the 2-step thresholding methods
compared with radiologist’s initial read.
Discussion
Continuous developments of magnetic resonance systems have
transformed this domain from a pure imaging system to a
sophisticated precise metric system that generates a substantial
amount of information and data. The complex structure of the
clinical data generated often does not ease the difficulty in
discriminating between different diagnoses and promotes
adoption of intelligent CDSs [55,56]. CDSs allow clinicians
and specialists to get insight into the data, test hypotheses, draw
conclusions, and directly interact with all the available
information. One should note that CDSs should aim to facilitate
optimal human performance by harnessing the most advanced
imaging and analysis techniques in conjunction with the end
user’s own decision-making skills and abilities.
Radiologists are moving toward quantitative imaging techniques
that are difficult to apply and complex to interpret [16,57].
MIROR is a real-time CDS, which can guide clinicians through
the implementation and analysis of advanced and new imaging
techniques and allow for these new methodologies to find
clinical acceptance through translational applications.
MIROR as a diagnostic tool allows its users to extract specific
region morphological features, request specific quantified
metrics and features (as a biomarker), and compare with relevant
findings available in its repository to gain maximal statistical
power with regard to outcome prediction for the input case into
the support system. MIROR can direct users to refine their
search patterns looking for particular diagnoses, even if they
themselves are not immediately aware of the significance of
these findings.
Use of modular programming in the development of MIROR
enforces logical boundaries between magnetic resonance
analysis applications, thereby improving maintainability [58,59].
Modularity has also allowed development and validation of
individual analysis techniques in separate studies to ensure
achievement of the important feature of any CDSs, which is its
accuracy and appropriateness of the system’s result.
In terms of its added clinical value and its impact on providing
clinical evidence, MIROR will assist clinicians to better
understand the pathophysiological difference between the
different tumor types and provide information that could help
them to better understand the mechanisms of diseases to improve
the diagnosis and prognosis of tumors. MRI biomarkers provide
information on both the tumor and its interaction with its
environment and can potentially provide new information, which
is not available from histology or tumor genetics. Analysis of
cancer imaging big data will allow uncovering the relation and
structure of cancer disease from an angle that has not previously
been viewed.
Although we concentrate on developing these advanced MRI
methods as a noninvasive diagnostic aid, they provide important
information on tissue properties. Apparent diffusion coefficient
shows a strong inverse correlation to cellularity—a key feature
of tumors and tumor aggressiveness. Likewise, there is an
increasing understanding that IVIM-f is related to tumor
vascularity, which is again an important pathophysiological
property of the tumor. Making these advanced MRI techniques
available to clinicians in their multidisciplinary team meetings,
where imaging and histopathology are evaluated together for
individual cases, is an important goal and will allow an improved
understanding of pathophysiology for these tumors in vivo and
ex vivo.
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Limitations
As a part of future research, we plan to work on functionality
and intelligent scaling of quantitative applications of MIROR
by further enhancing its statistical capabilities and extension to
more embedded advanced quantitative analysis modules such
as magnetic resonance spectroscopy and integration of real-time
interactive machine learning to optimize the use of available
data in MIROR based on the guidelines [60].
It should be noted that a major limitation of the study was that
MIROR was trained and tested with a rather limited set of data
analyzed retrospectively. A major focus of future work will be
the validation of the tool based on a prospective dataset in real
time and in a multicenter clinical setting to reinforce the
credibility, usability, and efficiency of the proposed CDSs
applications.
Conclusions
The proposed CDS is a diagnostic tool and repository that allows
the interpretation and analysis of magnetic resonance images
to be more accessible and comprehensive for clinicians. The
process and experiences described here provide a model for
development of the other CDSs attempting to perform a
nonregion-specific quantitative analysis of MRI data. MIROR
aims to increase clinician’s skillset by introducing newer
techniques and up-to-date findings to their repertoire and make
information from previous cases available to aid decision
making. The modular-based format of the tool allowed
integration of analyses that are not readily available clinically,
and streamlines future developments. Pipelines for new analysis
applications are available or already in development and will
be shortly available under the MIROR platform.
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